LeMaitre Vascular, Inc. (LMAT) Revenue History
LeMaitre Vascular, Inc. (LMAT) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2016-12-31 | $89.15M |
| 2017-12-31 | $100.87M |
| 2018-12-31 | $105.57M |
| 2019-12-31 | $117.23M |
| 2020-12-31 | $129.37M |
| 2021-12-31 | $154.42M |
| 2022-12-31 | $161.65M |
| 2023-12-31 | $193.48M |
| 2024-12-31 | $219.86M |
| 2025-12-31 | $249.60M |
How LMAT compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| HROW | Harrow Inc Com | $272.30M |
| IOVA | Iovance Biotherapeutics Inc. | $263.50M |
| AKBA | Akebia Therapeutics Inc. | $236.20M |
| CERS | Cerus Corporation | $233.80M |
| AXGN | Axogen Inc. | $225.21M |
These are five companies in the same sector as LMAT with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get LeMaitre Vascular, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("LMAT", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | LMAT | $83.87 | +2.88% | 0.25M |
| 3 | ||||
| 4 | ||||
| 5 |